Saturday, December 3, 2022


Biotechnology News Magazine


Eagle Genomics Announces USD 20M First Close; Scale-up Funding to Accelerate the Application of Microbiome Science for Global ‘One Health’ Innovation

Eagle Genomics advises the round is being led by abrdn plc, with continued participation from existing investors Environmental Technologies Fund, and a consortium of investors headed by Granpool Innovative Investments.

AgroSpheres Raises $22 million Series B

AgroSpheres notes the round was led by Lewis & Clark AgriFood and Ospraie Ag Science.

Day Zero Diagnostics Awarded $8.2 Million in Additional CARB-X Funding To Support Ongoing Development of its Infectious Disease Rapid Diagnostic

Day Zero Diagnostics received an initial $6.2 million CARB-X award in May of 2020. This latest award brings the total to over $16 million.

RenBio Announces the Award of Two Grants to Support Continued Development of Its Novel DNA Therapeutics MYO Technology™ Platform for Infectious Disease Applications

RenBio notes the goal of the $40.0 million New York State Biodefense Commercialization Fund is to accelerate the development and commercialization of innovations targeting infectious disease threats while fostering new life science businesses and industry growth within the State.

Nested Therapeutics Launches With $125 Million Financing

Financing will enable Nested Therapeutics to advance its pipeline programs, attract additional top-tier talent, and further develop its platform that reveals cryptic, or newly uncovered, driver mutations and pockets in high-conviction cancer targets to dramatically expand the reach of precision medicine.

Araris Biotech Closes $24 Million Financing Round

Araris Biotech notes the proceeds from the financing will be used to support the further development and advancement of Araris’ antibody-drug conjugate (ADC) candidates, created using the Company’s proprietary linker technology, as Araris moves closer toward clinical development.